Executive Assistant

The Executive Assistant is responsible for providing administrative and secretarial support to the Company’s Leadership Team. This role is a key member of the administrative team and leads all administrative efforts for Elicio’s Leadership team.

The person in this role will coordinate a high level of appointment scheduling, meeting notation, travel arrangements, expense reimbursement, meeting coordination, preparing presentation materials, and assisting with office and company operational needs.

Elicio (ELTX) is a growing organization based out of the Seaport area of Boston, Massachusetts with additional staff functioning in a virtual based environment from the Greater Boston area and throughout the United States.

• Provide administrative support to Elicio’s Leadership Team
• Proactively manager calendars with the ability to schedule and prioritize meetings, resolve schedule conflicts, and ensure efficient and positive experiences for attendees
• Manage and prioritize internal and external communications for key stakeholders
• Handle confidential and proprietary information with discretion
• Manage specific vendors
• Coordinate both onsite and offsite meetings for the Leadership team
• Coordinate and organize travel, hotel accommodations, car service, preparation of itineraries/materials, etc.
• Schedule numerous weekly meetings
• Assist with company administrative duties, including office management/Human Resources tasks as needs arise
• Responsible for taking notes and minutes in key meetings
• Act as a point person for visitors, executives, and investors

Required:

• Minimum of 2 years of related experience with a Bachelor’s degree or 4 years of related experience without a secondary degree
• Prior biotech experience, preferably supporting leadership teams
• Prior experience in an Executive Assistant role
• Work experience with a public company is desirable but not required

• Strong computer, scheduling and coordination skills
• Ability to be proactive and a comfort with working remotely when necessary
• Proficiency in Microsoft Office, Outlook, Zoom and MS Teams
• Ability to work with onsite, hybrid and remote employees
• Excellent communication skills; the ability to collaborate effectively with cross-functional teams, vendors and internal and external partners
• Strong team player with the ability to work in a fast-paced environment, manage competing priorities, while filling gaps as needed
• Strong problem-solving skills and self-motivated with the ability to work under pressure to meet deadlines
• Ability to prioritize and manage through complex processes/projects
• Effective in promoting and maintaining productive internal and external relationships
• Flexible and creative to meet the needs of a growing, dynamic company

Busy office/laboratory environment with frequent deadlines and interruptions

Travel is not required

Subject to periods of sitting or standing, vision is required to monitor data.

This role can be onsite, hybrid or remote.

Elicio Therapeutics, Inc.(Nasdaq: ELTX) is a clinical-stage biotechnology company advancing novel immunotherapies to prevent the recurrence of high-prevalence cancers, including mKRAS-positive pancreatic and colorectal cancers. Elicio intends to build on recent clinical successes in the personalized cancer vaccine space to develop effective, off-the-shelf vaccines. Elicio’s Amphiphile (“AMP”) technology aims to enhance the education, activation and amplification of cancer‑specific T cells relative to conventional vaccination strategies, with the goal of promoting durable cancer immunosurveillance in patients.

Elicio’s ELI‑002 lead program is an off‑the‑shelf vaccine candidate targeting the most common KRAS mutations, which drive approximately 25% of all solid tumors. ELI‑002 is being studied in an ongoing, randomized clinical trial in patients with mKRAS‑positive pancreatic cancer who completed standard therapy. Elicio’s pipeline includes additional off‑the‑shelf therapeutic cancer vaccines, including ELI‑007 and ELI‑008, that target BRAF‑driven cancers and p53 hotspot…